Yarrow Bioscience, Inc. - Common Stock, $0.0001 par value (YARW)

CUSIP: 92941V407

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 5 signals
Share change
+20
SEC-reported price per share
$22.50
Number of holders
1
Value change
+$450
Number of buys
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,433,962

Security key

92941V407

Report period

Q3 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of YARW - Yarrow Bioscience, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Logos Global Management LP
Disclosed value leader
Bellevue Group AG
Comparable rows
12/15
Latest evidence
11 Sep 2026
13D/G 3/4/5 13F Lead comparable stake: 11% 3 rows are not safely comparable across share classes. 13D/G row: Logos Global Management LP Showing 1-6 of 15 holder rows.

Quick read

Logos Global Management LP leads the comparable SEC ownership view at 11%.

12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Logos Global Management LP's linked filing trail.
Comparable ownership Top 5
Logos Global Management LP 11%
Bellevue Group AG 11%
RTW Fund Group GP, LLC 10%
PERCEPTIVE ADVISORS LLC 10%
venBio Global Strategic Fund V, L.P. 10%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Logos Global Management LP
13D/G
11%
Reported 13D/G · 31 Jul 2026
—
286,308 shares
$0 31 Jul 2026
Bellevue Group AG
13D/G
11%
Reported 13D/G · 10 Sep 2026
$27,010,000
1,000,000 shares
$0 10 Sep 2026
RTW Fund Group GP, LLC
3/4/5 13D/G
10%+ Owner
10%
Reported 13D/G · 27 Jul 2026
$173,285
9,216,026 shares
mixed-class rows
— 29 Jul 2026
PERCEPTIVE ADVISORS LLC
3/4/5 13D/G
10%+ Owner
10%
Reported 13D/G · 27 Jul 2026
$173,234
266,309 shares
— 27 Jul 2026
venBio Global Strategic Fund V, L.P.
13D/G
10%
Reported 13D/G · 27 Jul 2026
—
279,340 shares
$0 27 Jul 2026
Janus Henderson Group Ltd.
13D/G
10%
Reported 13D/G · 31 Jul 2026
—
266,712 shares
$0 31 Jul 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
20
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
0
Q3 2026 holders
1
Holder diff
1
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .